Biofrontera BFRI
NASDAQ BFRI
$1.09 -0.04 (-3.54%)
At close: Sep 29, 2026 · 4:00 PM EDT

Biofrontera (BFRI) Share-based Compensation (2022 - 2025)

Updated

Biofrontera (BFRI) reported Share-based Compensation of $289,000 for Q4 2025, down 3.3% from $299,000 a year earlier but up 22.5% from the prior quarter.

Analysis

Biofrontera (BFRI) Share-based Compensation (2022 - 2025) Analysis & Trends

For FY2025, Biofrontera posted Share-based Compensation of $951,000, down 6.7% from FY2024.

  • Share-based Compensation has declined for three consecutive years, though with a four-year compound annual growth rate of 64.8% (FY2021 to FY2025).
  • By year, Share-based Compensation came in at $1.02 million in FY2024 (-2.5%), $1.05 million in FY2023 (-43.6%), $1.85 million in FY2022 and $129,000 in FY2021.
  • Five-year quarterly Share-based Compensation spans a low of $187,000 in Q2 2025 and a high of $551,000 in Q2 2022.
  • Year over year, Share-based Compensation has now declined in each of the last three quarters, with an average decline of 1.4% over the last eight quarters.
  • The high point for year-over-year Share-based Compensation in five years was Q3 2024 (growth of 39.1%); the low point was Q2 2023 (a decline of 53.0%).
  • Per Business Quant data, the three quarters before Q4 2025 came in at $236,000 (Q3 2025), $187,000 (Q2 2025) and $239,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Biofrontera 16.05 Mn -5.74 Mn 9.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 289,000.00
Sep 30, 2025 236,000.00
Jun 30, 2025 187,000.00
Mar 31, 2025 239,000.00
Dec 31, 2024 299,000.00
Sep 30, 2024 288,000.00
Jun 30, 2024 204,000.00
Mar 31, 2024 228,000.00
Dec 31, 2023 228,000.00
Sep 30, 2023 207,000.00
Jun 30, 2023 259,000.00
Mar 31, 2023 351,000.00
Dec 31, 2022 383,000.00
Sep 30, 2022 401,000.00
Jun 30, 2022 551,000.00
Mar 31, 2022 517,000.00
API Access

Biofrontera Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BFRI&period=max&api_key=YOUR_API_KEY